The role of STAT3 in HNSCC cell CTX that acquires resistance is supported by recovering increased sensitivity to CTX (greater antiproliferative effects and cytotoxicity) when STAT3 is knocked down (104) or by blocking JAK2–STAT3 signaling (using miR-204) (101). Here, JAK2 is linked to head and neck squamous cell carcinoma.